AAV vector engineering for human aorta transduction: becoming a smooth operator

被引：0
|
作者：
Rapti, Kleopatra [1 ]
Grimm, Dirk [1 ,2 ,3 ,4 ]
机构：
[1] Heidelberg Univ, Sect Viral Vector Technol, Ctr Integrat Infect Dis CIID, Dept Infect Dis Virol,Med Fac,BioQuant, D-69120 Heidelberg, Germany
[2] German Ctr Infect Res DZ, D-69120 Heidelberg, Germany
[3] German Ctr Cardiovasc Res DZHK, Partner Site Heidelberg, D-69120 Heidelberg, Germany
[4] Heidelberg Univ, Fac Engn Sci, D-69120 Heidelberg, Germany
来源：
GENE THERAPY | 2025年
关键词：
MUSCLE-CELLS; EFFICIENT TRANSDUCTION; ADENOASSOCIATED VIRUS; GENE-TRANSFER; DELIVERY;
D O I：
10.1038/s41434-025-00526-9
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The human brain endothelial barrier: transcytosis of AAV9, transduction by AAV2
    Weber-Adrian, Danielle
    Heinen, Stefan
    Silburt, Joseph
    Noroozian, Zeinab
    Aubert, Isabelle
    JOURNAL OF NEUROCHEMISTRY, 2017, 140 (02) : 192 - 194
  • [42] Chemical engineering of AAV capsids improves their biodistribution and transduction properties in neural tissues
    Lefevre, G. M.
    Burlot, M. A.
    Brument, N.
    Jordi, E.
    Gougerot, A.
    Blaettler, T.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A30 - A30
  • [43] Improvement of Transduction Efficiency of Adeno-Associated Vector (AAV) by Extracellular Vesicles (EVs)
    Matsuzaka, Yasunari
    MOLECULAR THERAPY, 2024, 32 (04) : 727 - 727
  • [44] Elucidating the Mechanism of Species Specificity of Recombinant AAV Capsid Vector-Mediated Transduction
    Tsuji, Shinnosuke
    Kay, Mark A.
    MOLECULAR THERAPY, 2019, 27 (04) : 220 - 221
  • [45] U2 snRNP Spliceosome Proteins Block Recombinant AAV Vector Transduction
    Schreiber, Claire
    Sakuma, Toshie
    Izumiya, Yoshihiro
    Holditch, Sara
    Hickey, Raymond
    Bressin, Robert
    Basu, Upamanyu
    Koide, Kazunori
    Asokan, Aravind
    Ikeda, Yasuhiro
    MOLECULAR THERAPY, 2015, 23 : S18 - S18
  • [46] Further Characterization of U2 snRNP Mediated Restriction of AAV Vector Transduction
    Schreiber, Claire A.
    Izumiya, Yoshihiro
    Asokan, Aravind
    Ikeda, Yasuhiro
    MOLECULAR THERAPY, 2016, 24 : S4 - S5
  • [47] Simple Methods to Increase AAV Vector Production by Improving Transduction and Altering Downstream Processing
    Wopat, Mitchell J.
    Carrig, Sean
    Martino, Ashley T.
    MOLECULAR THERAPY, 2017, 25 (05) : 260 - 261
  • [48] Optimized vector purification and delivery methods to achieve enhanced liver transduction by AAV vectors
    Ayuso, Eduard
    Montane, Joel
    Mingozzi, Federico
    Anguela, Xavier M.
    Leon, Xavier
    Mann, Christopher
    Callejas, David
    Jimenez, Veronica
    Tafuro, Sabrina
    Andaluz, Anna
    Garcia, Felix
    Zhou, Shangzhen
    Wright, Fraiser
    High, Katherine A.
    Bosch, Fatima
    HUMAN GENE THERAPY, 2008, 19 (10) : 1118 - 1119
  • [49] Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain
    Cearley, Cassia N.
    Vandenberghe, Luk H.
    Parente, Michael K.
    Carnish, Erin R.
    Wilson, James M.
    Wolfe, John H.
    MOLECULAR THERAPY, 2008, 16 (10) : 1710 - 1718
  • [50] Identification of barriers to AAV transduction in the heart: focus on receptor availability and intracellular vector processing
    Kraszewska, I.
    Andrysiak, K.
    Kopacz, A.
    Sarad, K.
    Dulak, J.
    Jazwa-Kusior, A.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A24 - A24
12345